查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2028 年全球临床研究服务市场预测
市场调查报告书
商品编码
1410063

2023-2028 年全球临床研究服务市场预测

Global Clinical Research Services Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

临床研究服务市场预计将从2021年的591.03亿美元成长到2028年的880.29亿美元，复合年增长率为5.86%。

慢性病发病率的增加、对循证医疗保健的需求不断增加以及药物和设备核准的监管要求正在推动临床研究服务市场的成长。由于国际上对这些服务的强劲需求，临床研究服务市场正在显着扩大。 CRO（委外研发机构）、大学研究机构和提供临床研究服务的专业公司正在争夺临床研究服务市场的份额。随着临床试验复杂性的增加和全球合作的扩大，临床研究服务市场规模预计将进一步扩大，从而促进医学的改进和新药的开发。

介绍

不断成长的临床研究服务市场是医疗保健产业中一个快速成长的领域，包括旨在协助临床试验的创建和进行的各种服务。临床研究服务对于推进医学知识、评估新药的安全性和有效性以及确保监管合规性至关重要。

临床研究服务包括试验设计、病患招募、资料管理、现场监测、统计分析和监管备案。 CRO（委外研发机构）、大学研究机构和其他专业组织提供这些服务。随着临床试验复杂性、全球合作和技术改进的增加，临床研究服务的市场规模预计将显着成长。这项扩张预计将有助于发现新药、提高病人安全和改善整个医学。

临床研究服务市场的主要企业

  • IQVIA： IQVIA 是临床研究服务的世界领导者，提供广泛的服务，包括试验设计、设施管理、病患招募和资料管理。
  • 美国实验室控股公司（LabCorp）： LabCorp 被称为临床研究服务供应商，包括临床试验、生物标记测试、中心实验室服务和临床试验管理解决方案。
  • PAREXEL INTERNATIONAL CORPORATION： PAREXEL INTERNATIONAL CORPORATION：提供全面的临床研究服务，包括临床试验管理、资料管理、监管建议和病患招募。
  • ICON plc： ICON 提供从头到尾的临床研究服务，包括临床试验设计、地点选择、病患招募、资料管理和监管支援。

对循证医疗保健的需求不断增长

对循证医疗保健的需求不断增长，表明人们越来越注重使用科学证据和严格的研究来为医疗决策提供资讯并改善患者的治疗结果。这种方法旨在确保医疗干预、治疗和卫生政策基于有效性、安全性和成本效益的可靠证据。实证医疗保健的目标是透过将最佳现有证据与临床经验和患者选择相结合，弥合研究与实践之间的差距。这种需求的动机是提高护理品质、减少实践差异以及有效分配医疗保健资源。

临床研究活动外包

临床研究业务外包是指将临床试验和研究的特定部分委託给CRO（合约药物委外研发机构）等外部服务供应商。这使得製药和生物技术公司能够利用专业组织的知识和资源，减轻内部团队的负担并提高业务效率。外包的好处包括扩充性、降低成本以及更快招募研究参与者。外包使公司能够专注于其核心竞争力，同时确保合规性和按时完成临床试验。总体而言，外包有助于加快药物开发过程并加强医学研究。

生物製药和生技产业的扩张

生物製药和生技产业的扩张是指这些领域的显着成长和发展。这种扩张是由研发投资增加、技术突破和创新药物发现等因素所推动的。慢性病发病率的增加、个体化医疗方法以及对新治疗方法的需求都在推动市场成长。因此，对支持新药、生技药品和医疗设备的发现和测试的临床研究服务的需求不断增加，临床研究服务市场预计将成长。

临床研究服务市场在预测期内将持续成长

临床研究服务市场按服务类型、治疗领域、最终用户和地区进行细分。服务类型进一步分为临床资料管理服务、品管服务、临床监测服务等。最终用户进一步分为製药和生物技术公司、受託研究机构以及学术和研究机构。

北美引领临床研究服务市场

北美在临床研究服务市场份额中占据主导地位。该地区的优势因素包括完善的医疗基础设施、蓬勃发展的製药和生物技术产业以及有利的法规环境。此外，大型委外研发机构（CRO）和大学研究机构遍布整个北美。美国尤其发挥关键作用，因为其在临床研究方面的巨大投资和大量正在进行的临床试验。儘管欧洲和亚太地区等其他地区也是临床研究服务市场的重要参与企业，但北美占据了压倒性的份额。

主要进展

2023年6月，IQVIA RIM智慧标籤发布。它是生命科学领域的综合标籤解决方案，提供主导驱动策略，以实现更有效率、更合规的全球标籤管理。生命科学公司可以利用这种独特的技术来简化规划、追踪和实施监管标籤的系统和流程。 2023 年 5 月，领先的基因药物製造商 Forge Biologics 宣布与全球生命科学公司 LabCorp 建立基因疗法药物研究和製造合作伙伴关係。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 资讯来源
  • 研究设计

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 业内竞争对手之间的对抗关係
  • 产业价值链分析

第五章全球临床研究服务市场：依服务类型

  • 介绍
  • 临床试验管理服务
  • 临床资料管理服务
  • 监管服务
  • 临床监测服务
  • 品管服务
  • 生物分析服务
  • 其他的

第六章全球临床研究服务市场：依治疗领域

  • 介绍
  • 肿瘤学
  • 心血管疾病
  • 感染疾病
  • 神经病学
  • 呼吸系统疾病
  • 其他的

第七章全球临床研究服务市场：依最终使用者分类

  • 介绍
  • 製药和生物技术公司
  • 委託研究组织（CROS）
  • 学术研究机构
  • 其他的
  • 全球临床研究服务市场：按地区
  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 台湾
    • 其他的

第八章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 合併、收购、协议和合作
  • 供应商竞争力矩阵

第九章 公司简介

  • IQVIA HOLDINGS INC.
  • PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC（PPD）
  • PAREXEL INTERNATIONAL CORPORATION
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • COVANCE INC.（A SUBSIDIARY OF LABORATORY CORPORATION OF AMERICA HOLDINGS）
  • SYNEOS HEALTH INC.
  • MEDPACE HOLDINGS, INC.
  • WUXI APPTEC INC.
  • ICON PLC
  • SGS SA
简介目录
Product Code: KSI061615739

The global clinical research services market is expected to grow at a CAGR of 5.86% from US$59.103 billion in 2021 to US$88.029 billion in 2028.

The rising frequency of chronic illnesses, increased demand for evidence-based healthcare, and regulatory requirements for medication and device approvals are propelling global clinical research services market growth. Given the strong demand for these services internationally, the global clinical research services market size is expanding significantly. Contract Research Organisations (CROs), university research organizations, and specialized companies providing clinical research services compete for the global clinical research services market share. As clinical trial complexity rises and worldwide collaboration expands, the global clinical research services market size is predicted to expand further, allowing improvements in medical science and the development of novel medicines.

Introduction:

The global clinical research services market growth is a booming area of the healthcare industry that includes a diverse variety of services targeted at assisting in the creation and execution of clinical trials. Clinical research services are critical in furthering medical knowledge, assessing the safety and efficacy of novel medicines, and assuring regulatory compliance.

Clinical research services include study design, patient recruiting, data management, site monitoring, statistical analysis, and regulatory filings, among other things. Contract research organizations (CROs), university research organizations, and other specialized entities provide these services. The global clinical research services market size is expected to develop significantly as clinical trial complexity, worldwide collaboration, and technology improvements increase. This expansion is projected to aid in the discovery of novel medicines, improve patient safety, and contribute to the improvement of medical science as a whole.

Key Players in the Global Clinical Research Services Market:

  • IQVIA: IQVIA is a global leader in clinical research services, providing a wide variety of services such as study design, site administration, patient recruiting, and data management.
  • Laboratory Corporation of America Holdings (LabCorp): LabCorp is a well-known clinical research services provider, including clinical trial testing, biomarker testing, central laboratory services, and clinical trial management solutions.
  • PAREXEL International Corporation: PAREXEL offers a comprehensive variety of clinical research services, including clinical trial management, data management, regulatory advice, and patient recruiting.
  • ICON plc: ICON provides clinical research services from start to finish, including clinical trial design, site selection, patient recruiting, data administration, and regulatory assistance.

Drives:

Growing Demand for Evidence-Based Healthcare:

The increased demand for evidence-based healthcare indicates a rising emphasis on using scientific evidence and rigorous research to inform medical decision-making and enhance patient outcomes. This method seeks to guarantee that medical interventions, therapies, and healthcare policies are based on trustworthy evidence of efficacy, safety, and cost-effectiveness. The goal of evidence-based healthcare is to close the gap between research and practice by combining the best available evidence with clinical experience and patient choices. This need is motivated by a desire for better treatment quality, less variability in practice, and a more efficient allocation of healthcare resources.

Outsourcing of Clinical Research Activities:

Clinical research operations are outsourced when specific components of clinical trials and research are delegated to external service providers such as Contract Research Organisations (CROs). This practice enables pharmaceutical and biotechnology firms to tap into the knowledge and resources of specialized organizations, lowering the pressure on in-house teams and enhancing operational efficiency. Outsourcing provides advantages such as enhanced scalability, cost savings, and speedier recruitment of research participants. It enables businesses to focus on their core capabilities while assuring regulatory compliance and clinical trial completion on schedule. Overall, outsourcing helps to speed the drug development process and enhance medical research.

Expansion of Biopharmaceutical and Biotechnology Industries:

The biopharmaceutical and biotechnology industries' expansion refers to the tremendous growth and development seen in these areas. This expansion is being driven by causes such as increasing investment in R&D, technological breakthroughs, and the discovery of innovative medicines. The rising frequency of chronic illnesses, personalized medical methods, and the need for novel therapies all help to drive market growth. As a consequence, there is a greater need for clinical research services to assist in the discovery and testing of novel pharmaceuticals, biologics, and medical devices, resulting in the potential for growth in the clinical research services market.

The Global Clinical Research Services Market is growing at a constant pace in the forecast period.

The market for global clinical research services is segmented by service type, therapeutic area, end-user, and geography. Service type is further segmented into clinical data management services, quality management services, clinical monitoring services, etc. End-users are further segmented into pharmaceutical and biotechnological companies, contract research organizations, and academic and research institutions.

North America is the Market Leader in the Global Clinical Research Services Market.

North America dominates the global clinical research services market share. Factors contributing to the region's supremacy include a well-established healthcare infrastructure, a thriving pharmaceutical and biotechnology industry, and a favorable regulatory environment. Furthermore, big contract research organizations (CROs) and university research organizations are well-represented throughout North America. Because of its enormous investment in clinical research and the vast number of ongoing clinical trials, the United States, in particular, plays a critical role. While other areas, such as Europe and the Asia Pacific, are important participants in the Global Clinical Research Services Market, North America has the dominant global clinical research services market share.

Key Developments:

  • In June 2023, IQVIA RIM Smart Labelling, a comprehensive labeling solution for the life sciences sector that delivers an intelligence-driven strategy for more efficient and compliant worldwide label management, was launched. Life sciences firms may use this one-of-a-kind technology to streamline regulatory label planning, tracking, and execution systems and processes.
  • In May 2023, Forge Biologics, a major maker of genetic medicines, announced a cooperation with LabCorp, a renowned global life sciences firm, to research and manufacture gene therapies.

Segmentation

By Service Type

  • Clinical Trial Management Services
  • Clinical Data Management Services
  • Regulatory Services
  • Clinical Monitoring Services
  • Quality Management Services
  • Bioanalytical Services
  • Others

By Therapeutic Area

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurology
  • Respiratory Diseases
  • Others

By End-User

  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations (Cros)
  • Academic And Research Institutions
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Sources
  • 2.3. Research Design

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY SERVICE TYPE

  • 5.1. Introduction
  • 5.2. CLINICAL TRIAL MANAGEMENT SERVICES
  • 5.3. CLINICAL DATA MANAGEMENT SERVICES
  • 5.4. REGULATORY SERVICES
  • 5.5. CLINICAL MONITORING SERVICES
  • 5.6. QUALITY MANAGEMENT SERVICES
  • 5.7. BIOANALYTICAL SERVICES
  • 5.8. OTHERS

6. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY THERAPEUTIC AREA

  • 6.1. Introduction
  • 6.2. ONCOLOGY
  • 6.3. CARDIOVASCULAR DISEASES
  • 6.4. INFECTIOUS DISEASES
  • 6.5. NEUROLOGY
  • 6.6. RESPIRATORY DISEASES
  • 6.7. OTHERS

7. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 7.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
  • 7.4. ACADEMIC AND RESEARCH INSTITUTIONS
  • 7.5. OTHERS
  • 7.6. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY GEOGRAPHY
  • 7.7. Introduction
  • 7.8. North America
    • 7.8.1. United States
    • 7.8.2. Canada
    • 7.8.3. Mexico
  • 7.9. South America
    • 7.9.1. Brazil
    • 7.9.2. Argentina
    • 7.9.3. Others
  • 7.10. Europe
    • 7.10.1. United Kingdom
    • 7.10.2. Germany
    • 7.10.3. France
    • 7.10.4. Italy
    • 7.10.5. Spain
    • 7.10.6. Others
  • 7.11. Middle East and Africa
    • 7.11.1. Saudi Arabia
    • 7.11.2. UAE
    • 7.11.3. Others
  • 7.12. Asia Pacific
    • 7.12.1. Japan
    • 7.12.2. China
    • 7.12.3. India
    • 7.12.4. South Korea
    • 7.12.5. Indonesia
    • 7.12.6. Taiwan
    • 7.12.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

  • 9.1. IQVIA HOLDINGS INC.
  • 9.2. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPD)
  • 9.3. PAREXEL INTERNATIONAL CORPORATION
  • 9.4. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 9.5. COVANCE INC. (A SUBSIDIARY OF LABORATORY CORPORATION OF AMERICA HOLDINGS)
  • 9.6. SYNEOS HEALTH INC.
  • 9.7. MEDPACE HOLDINGS, INC.
  • 9.8. WUXI APPTEC INC.
  • 9.9. ICON PLC
  • 9.10. SGS SA